» Authors » C F van Nostrum

C F van Nostrum

Explore the profile of C F van Nostrum including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 29
Citations 660
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Farnoudian-Habibi A, Aliebrahimi S, Sehati F, Nabavizadeh F, Asadi H, Montazeri V, et al.
Int J Pharm . 2024 Aug; 663:124561. PMID: 39111356
According to the importance of time in treatment of thrombosis disorders, faster than current treatments are required. For the first time, this research discloses a novel strategy for rapid dissolution...
2.
Rooimans T, Damen M, Markesteijn C, Schuurmans C, de Zoete N, van Hasselt P, et al.
Int J Pharm . 2023 Apr; 640:122960. PMID: 37061210
Propofol is the preferred anaesthetic for induction and maintenance of sedation in critically ill mechanically ventilated COVID-19 patients. However, during the outbreak of the COVID-19 pandemic, regular supply chains could...
3.
Ritsema J, Herschberg E, Borgos S, Lovmo C, Schmid R, Te Welscher Y, et al.
Int J Pharm . 2017 Nov; 548(2):730-739. PMID: 29133206
In the field of nanomedicine, nanoparticles are developed to target antibiotics to sites of bacterial infection thus enabling adequate drug exposure and decrease development of resistant bacteria. In the present...
4.
Kazazi-Hyseni F, van Vuuren S, van der Giezen D, Pieters E, Ramazani F, Rodriguez S, et al.
Acta Biomater . 2015 May; 22:141-54. PMID: 25929814
Subcapsular renal injection is a novel administration method for local delivery of therapeutics for the treatment of kidney related diseases. The aim of this study was to investigate the feasibility...
5.
Ramazani F, Hiemstra C, Steendam R, Kazazi-Hyseni F, van Nostrum C, Storm G, et al.
Eur J Pharm Biopharm . 2015 Feb; 95(Pt B):368-77. PMID: 25701807
Sunitinib is a multi-targeted receptor tyrosine kinase (RTK) inhibitor that blocks several angiogenesis related pathways. The aim of this study was to develop sunitinib-loaded polymeric microspheres that can be used...
6.
Ramazani F, Chen W, van Nostrum C, Storm G, Kiessling F, Lammers T, et al.
Int J Pharm . 2015 Feb; 482(1-2):123-30. PMID: 25636301
The aim of this study was the development of imatinib-loaded poly(d,l-lactide-co-glycolide) (PLGA) microspheres with high loading efficiency which can afford continuous release of imatinib over a prolonged period of time....
7.
Kazazi-Hyseni F, Zandstra J, Popa E, Goldschmeding R, Lathuile A, Veldhuis G, et al.
Int J Pharm . 2014 Dec; 482(1-2):99-109. PMID: 25497444
Poly(D,L-lactic-co-hydroxymethyl glycolic acid) (PLHMGA) is a biodegradable copolymer with potential as a novel carrier in polymeric drug delivery systems. In this study, the biocompatibility of PLHMGA microspheres (PLHMGA-ms) was investigated...
8.
Samadi N, Abbadessa A, Di Stefano A, van Nostrum C, Vermonden T, Rahimian S, et al.
J Control Release . 2013 Jun; 172(2):436-43. PMID: 23751568
The aim of this study was to investigate the effect of a specific and frequently used end group (lauryl alcohol) on the protein release and degradation kinetics of poly(DL-lactic-co-glycolic acid)...
9.
Samadi N, van Nostrum C, Vermonden T, Amidi M, Hennink W
Biomacromolecules . 2013 Mar; 14(4):1044-53. PMID: 23458350
The purpose of this study was to gain mechanistic insights into the effect of different formulation parameters on the degradation and release behavior of protein-loaded nanoparticulate carrier systems based on...
10.
Talelli M, Morita K, Rijcken C, Aben R, Lammers T, Scheeren H, et al.
Bioconjug Chem . 2011 Oct; 22(12):2519-30. PMID: 22017211
Doxorubicin is an anthracycline anticancer agent that is commonly used in the treatment of a variety of cancers, but its application is associated with severe side effects. Biodegradable and thermosensitive...